Cold Plasma in Healthcare Market to Reach USD 6,634 Million by 2032 - Credence Research

LONDON, Oct. 7, 2026 /PRNewswire/ -- The "Cold Plasma in Healthcare Market – Growth, Share, Opportunities & Competitive Analysis, 2025–2032" report has been added to the Credence Research Inc. offering.

The global Cold Plasma in Healthcare Market was valued at USD 2,873 million in 2025 and is projected to reach USD 6,634 million by 2032, registering a CAGR of 12.7%. Growth is being supported by expanding clinical interest in non-thermal plasma for wound management, microbial control, dermatology, dental applications and device-related sterilization workflows. Point-of-care atmospheric systems are gaining importance because they can be deployed without high-temperature treatment, while device makers are increasingly pairing hardware with consumables, training and service support to improve treatment standardization.

Key Takeaways

• The Cold Plasma in Healthcare Market is projected to grow from USD 2,873 million in 2025 to USD 6,634 million by 2032 at a CAGR of 12.7%.
• Devices led the product segment with 68.4% share in 2025, reflecting the importance of installed treatment capability before recurring consumable and service revenue scales.
• Plasma Jet held 39.6% of the technology segment, while Atmospheric Pressure Cold Plasma accounted for 66.8% of the pressure-type segment in 2025.
• Wound Healing and Chronic Wound Management was the leading application with 28.9% share, supported by repeat-treatment workflows and strong clinical interest in microbial control.
• Hospitals represented 41.7% of end-user demand in 2025, while outpatient and specialty settings are emerging as important expansion channels.
• North America led with 38.9% share in 2025, followed by Europe at 31.2% and Asia Pacific at 21.0%.

Scope & Segmentation – Cold Plasma in Healthcare Market

The report provides a comprehensive analysis of the global Cold Plasma in Healthcare Market, covering revenue forecasts through 2032. It evaluates product models, plasma technologies, pressure formats, clinical applications, end-user settings, regional adoption and competitive development.

The study places particular emphasis on medically relevant cold-plasma platforms and clinically adjacent technologies, including suppliers active in medical devices, wound care, disinfection and other healthcare applications.

• The Cold Plasma in Healthcare Market is segmented based on product type, technology, pressure type, application, end user and region.
• By Product Type, the market includes Devices, Consumables, and Services and Software.
• By Technology, the market includes Dielectric Barrier Discharge, Plasma Jet, Radio-Frequency Cold Plasma, Microwave Cold Plasma, and Other Cold Plasma Technologies.
• By Pressure Type, the market includes Atmospheric Pressure Cold Plasma and Low-Pressure / Vacuum Cold Plasma.
• By Application, the market includes Wound Healing and Chronic Wound Management, Oncology Applications, Hemostasis and Blood Coagulation, Dentistry and Oral Care, Dermatology, Sterilization and Disinfection, Implant Surface Functionalization, and Plasma-Activated Liquids and Hydrogels.
• By End User, the market includes Hospitals, Ambulatory Surgical Centers, Wound Care Centers, Specialty Clinics, Research and Academic Institutes, and Home Care Settings.
• By Region, the market is analyzed across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Access crucial information at unmatched prices!

Request your sample report today and start making informed decisions powered by Credence Research Inc. https://www.credenceresearch.com/report/cold-plasma-in-healthcare-market

Why This Report Matters

• The report provides a focused view of a healthcare technology category moving from specialist use toward broader clinical and outpatient workflows.
• It helps decision-makers distinguish between cold-plasma device formats, pressure systems and application environments rather than treating plasma as a single technology class.
• The study highlights the importance of clinical evidence, training, service coverage and workflow fit in determining adoption speed.
• For medtech companies, hospitals, wound-care providers, distributors and investors, the report supports portfolio strategy, commercialization planning and regional market assessment.

Market Overview

• Industry Landscape and Value Chain Assessment
• Supply-Side Evaluation
• Demand-Side Evaluation
• Stakeholder Mapping
• Porter's Five Forces Review
• PESTLE Environment Assessment
• Market Forecast and Future Direction
• Short-Term Forecast, 0–2 Years
• Mid-Term Forecast, 3–5 Years
• Long-Term Forecast, 5–10 Years
• Market Entry and Expansion Strategy

Market Insights

• Clinical Adoption and Workflow Analysis
• Device and Consumables Economics
• Technology and Pressure-Type Benchmarking
• Application Opportunity Assessment
• Hospital and Outpatient Procurement Review
• Regulatory and Clinical Evidence Assessment
• Training and Service Infrastructure Review
• Regional Commercialization Analysis
• Investment Return and Market Expansion Assessment

Key Attributes

Segmentation

By Product Type

• Devices
• Consumables
• Services and Software

By Technology

• Dielectric Barrier Discharge
• Plasma Jet
• Radio-Frequency Cold Plasma
• Microwave Cold Plasma
• Other Cold Plasma Technologies

By Pressure Type

• Atmospheric Pressure Cold Plasma
• Low-Pressure / Vacuum Cold Plasma

By Application

• Wound Healing and Chronic Wound Management
• Oncology Applications
• Hemostasis and Blood Coagulation
• Dentistry and Oral Care
• Dermatology
• Sterilization and Disinfection
• Implant Surface Functionalization
• Plasma-Activated Liquids and Hydrogels

By End User

• Hospitals
• Ambulatory Surgical Centers
• Wound Care Centers
• Specialty Clinics
• Research and Academic Institutes
• Home Care Settings

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Chronic Wound Burden and Point-of-Care Adoption Support Growth

Wound management remains the clearest commercial pathway for cold plasma because chronic and difficult-to-heal wounds require repeated interventions, infection control and standardized clinical workflows. Non-thermal systems are attractive where providers want localized treatment without heat-related tissue damage, and the repeat-treatment model can support sustained device utilization once protocols are established.

Atmospheric pressure platforms are particularly relevant to bedside and outpatient settings because they avoid vacuum infrastructure and can be packaged in mobile or compact formats. This supports adoption in wound-care centers, specialty clinics and hospital departments where portability and simple setup influence treatment throughput.

Device-Led Adoption Expands into Outpatient and Specialty Care

Capital equipment currently anchors the market, but installed-base expansion creates downstream opportunities for consumables, maintenance, training and software-enabled documentation. Vendors that provide protocol support and clinician education can lower adoption friction and improve treatment reproducibility across sites.

Beyond wound care, cold plasma is being evaluated or applied in dentistry, dermatology, sterilization, implant surface treatment and other specialty workflows. The commercial opportunity differs by application maturity, so credible clinical evidence and clear regulatory positioning remain central to market development.

Market Challenges Include Clinical Evidence Requirements, Procurement Scrutiny and Service Coverage

Healthcare buyers require clear evidence of safety, reproducibility and workflow value before scaling new treatment modalities. The evidence base is stronger in selected wound-care uses than in some emerging applications, which can lead to different adoption timelines across the segmentation.

Capital equipment procurement competes with other hospital priorities, making total cost of ownership, staff training, maintenance and local service availability important purchasing considerations. Limited support infrastructure can slow expansion in newer markets even when clinical interest is present.

Regulatory status and approved indications differ across devices and geographies. Suppliers must therefore avoid overextending claims and align commercialization with jurisdiction-specific approvals, clinical protocols and practitioner training.

Key Player Analysis

• terraplasma medical GmbH
• neoplas med GmbH
• Plasmacure B.V.
• Coldplasmatech GmbH
• Adtec Healthcare / Adtec Plasma Technology
• Viromed Medical AG
• relyon plasma GmbH

Recent Industry Developments

• In February 2025, Royal Wound-X, a division of Royal Biologics, entered a strategic partnership with Coldplasmatech GmbH focused on complex and chronic wound care using Cold Atmospheric Plasma technology.
• In April 2025, Viromed Medical AG signed an exclusive distribution agreement with UMECO Group covering commercialization of the ViroCAP and PulmoPlas cold-plasma medical devices in ten Asian markets.
• In June 2025, neoplas med introduced its Argon Cold Plasma Jet kINPen MED in Oman at a launch event in Muscat attended by healthcare professionals from public and private institutions.

Report Coverage

• The research report offers an in-depth analysis based on Product Type, Technology, Pressure Type, Application, End User and Region.
• It assesses device adoption, clinical workflow fit, consumables and service economics, regional commercialization and competitive positioning.
• The report distinguishes established and emerging applications and evaluates clinical evidence, procurement, training and regulatory factors that influence adoption.
• It provides strategic guidance for medical device companies, healthcare providers, distributors and investors assessing cold-plasma commercialization opportunities.

Access crucial information at unmatched prices!

Request your sample report today and start making informed decisions powered by Credence Research Inc. https://www.credenceresearch.com/report/cold-plasma-in-healthcare-market 

Shape Your Report to Specific Countries or Regions and Enjoy 30% Off!

Customize Now

Related Reports –

https://www.credenceresearch.com/report/wound-care-market 

https://www.credenceresearch.com/report/advanced-wound-care-market 

https://www.credenceresearch.com/report/sterilization-technologies-market 

About Us

Credence Research Inc is a global market intelligence and consulting firm founded in 2015. It delivers deep market insights, quantitative analysis, and strategic guidance to business leaders, investors, governments, NGOs, and non-profit groups worldwide. The company helps organizations evaluate markets, understand trends, reduce risk, and make data-driven decisions that support growth and competitive strategy. Credence Research is known for rigorous research methods and comprehensive analytics.

The firm produces detailed reports covering market size, forecasts, growth drivers, trends, and competitive landscapes across many industries. Each report often includes frameworks like PESTLE and Porter's Five Forces to give a complete view of market dynamics and future potential. Credence Research also provides tailored consulting services, due diligence support, go-to-market planning, and pre-IPO research to strengthen client strategies and investment narratives. Its insights come from both primary and secondary research, expert interviews, and advanced data modelling. The firm's client base spans Europe, the Americas, Asia-Pacific, and the Middle East/Africa.

To find out more, visit www.credenceresearch.com or follow us on X.com, LinkedIn and Facebook

Contact Us –

Credence Research Inc,

Tower C-1105, S 25,

Akash Tower,

Vishal Nagar,

Pimple Nilakh, Haveli,

Pune – 411027, India

USA: +1 6282 627 656

UK: +44 7453 598 606

Email: sales@credenceresearch.com

Visit Our Website: https://www.credenceresearch.com/ 

View original content to download multimedia:https://www.prnewswire.com/news-releases/cold-plasma-in-healthcare-market-to-reach-usd-6-634-million-by-2032--credence-research-302901512.html

SOURCE Credence Research Inc.